Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Zealand Pharma A/S ADR (ZEAL)

Zealand Pharma A/S ADR (ZEAL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zealand Pharma A/S ADR SYDMARKEN 11 COPENHAGEN G7 2860 DNK

P: 45-8877-3600 F: +45 88773898

Description:

Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. Zealand Pharma A/S is based in Copenhagen, Denmark.

Key Statistics

Overview:

Market Capitalization, $K 818,603
Enterprise Value, $K 694,463
Shares Outstanding, K 46,538
Annual Sales, $ 46,550 K
Annual Net Income, $ -161,990 K
Last Quarter Sales, $ 4,060 K
Last Quarter Net Income, $ -69,960 K
60-Month Beta 1.45
% of Insider Shareholders 2.20%
% of Institutional Shareholders 1.73%
Float, K 45,514
% Float 97.80%
Short Volume Ratio 0.99

Growth:

1-Year Return -40.49%
3-Year Return -29.50%
5-Year Return -5.94%
5-Year Revenue Growth 33.42%
5-Year Earnings Growth -302.13%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.40 on 08/11/22
Next Earnings Date 11/10/22
Earnings Per Share ttm -3.76
EPS Growth vs. Prev Qtr -122.22%
EPS Growth vs. Prev Year -26.13%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ZEAL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -111.05%
Return-on-Assets % -56.54%
Profit Margin % -347.99
Net Margin % N/A
Debt/Equity 0.93
Price/Sales 17.38
Price/Cash Flow N/A
Price/Book 7.17
Book Value/Share 0.00
Interest Coverage -64.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar